Considerable on MSN
Pfizer channels COVID windfall into cancer
Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...
Stocktwits on MSN
TRAW stock slides in volatile session – what’s the latest on its phase 2 trial for COVID-19 treatment?
The open-label trial enrolled 90 patients and compared Ratutrelvir with Paxlovid, an oral antiviral medication from Pfizer.
SAN FRANCISCO -- One of the front-runners in the quest for a COVID-19 vaccine is reporting hopeful news. Pfizer says its vaccine is proving to be safe during phase three trials. RELATED: Oxford, ...
Pfizer-BioNTech has joined Moderna in testing its COVID-19 vaccine in children younger than 12, including babies as young as 6 months, with the possibility of expanding availability of the shot to the ...
Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in kids aged between 5 and 11. The results mark a key step in ...
Pfizer says COVID vaccine protection lasts at least 6 months; Company can now seek full FDA approval
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
Drug maker Pfizer says it's planning to start testing its COVID-19 vaccine on children as young as 12. This will be the first coronavirus vaccine trial to include children in the United States. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results